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Rational design of transcranial
alternating current stimulation:
Identification, engagement, and
validation of network oscillations
as treatment targets
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Abstract
Network oscillations in the brain are routinely recorded in the clinic and in the research lab. Here we outline a new
paradigm in which network oscillations serve as treatment targets for noninvasive brain stimulation. We show how
transcranial alternating current stimulation (tACS) can be used to modulate network oscillations that are impaired in
disorders of the central nervous system (CNS). Using rational design, a structured process of target identification, target
engagement, and target validation can be deployed to develop effective noninvasive brain stimulation paradigms for the
treatment of neurological and psychiatric illnesses. We conclude by outlining how this approach could be applied to two
disorders of the CNS, depression and epilepsy, for which there already exist clinical brain stimulation treatment options.
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Rhythmic structure is one of the main features of neuronal
activity.1,2 Since the discovery of the electroencephalo-
gram (EEG) by Hans Berger early in the 20th century,3 it
has been known that human brain activity measured at the
macroscale by scalp electrodes exhibits oscillatory fea-
tures. We today know that the rhythmic structure emerges
through complex interactions of intrinsic, synaptic, and
non-synaptic mechanisms, resulting in synchronization,
which leads to a superimposition of the weak electric fields
generated by individual neuronal elements. The emergent
macroscopic electric field thus reflects the coordinated
activity of a large number of neurons. Remarkably, the
study and interpretation of brain rhythms have taken
very different forms, depending on the specific scientific
field and clinical discipline. For example, epileptology and
sleep medicine have a long history of defining pathological
states and conditions through the presence of specific
oscillatory features in the EEG. Strikingly, the clinical
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conceptualization of pathological changes in brain rhythms
still mostly relies on the visual examination of EEG traces.
In stark contrast, there are neuroscience research commu-
nities that have traditionally discounted the presence of the
rhythmic organization measured by EEG (or as a local field
potential (LFP) from implanted electrodes in animal mod-
els) as an epiphenomenon. The recent advent of transcra-
nial alternating current stimulation (tACS) has revitalized
and partially resolved this debate about the causal role of
brain rhythms. This novel form of noninvasive brain stimu-
lation applies a weak sine-wave current to the brain via
scalp electrodes (Figure 1). With tACS, there is now a safe
tool at our disposal for noninvasive, targeted modulation of
human brain rhythms. What makes tACS attractive is that
the required hardware is lightweight and relatively cheap,
thus offering the opportunity of mobile and widespread
deployment of this brain stimulation technology. The obvi-
ous and exciting application of tACS in human neu-
roscience is to modulate a specific brain rhythm and
determine changes in cognition and behavior that have
been associated with this rhythm in previous EEG studies.
A quickly growing number of studies have been able to
demonstrate such causal links between brain oscillations
and specific cognitive functions such as working memory.4
A comprehensive review would be beyond the scope of this
article. Rather, we here focus on outlining a novel approach
of leveraging tACS as a neurotherapeutic for disorders of
the nervous system. In particular, we are developing a
rational design approach for the development of tACS as
clinical treatment tool. This approach is enabled by a tight
integration of research strategies from biology, engineer-
ing, and medicine. The fundamental challenge of tACS
(and many other types of brain stimulation) is that there
are uncountable parameter combinations that can be used
for stimulation paradigms. Any attempt of a detailed para-
meter exploration is thus bound to fail. Rational design
serves as a potential solution since it strives to gain a
mechanistic understanding of how tACS works, which will
then allow the theory-driven choice of optimal/optimized
parameters. In this approach, there are in essence three inter-
locked steps, which we refer to as target identification, tar-
get engagement, and target validation. Briefly, target
identification refers to work that aims to delineate how neu-
ronal oscillations mediate cognition and behavior and how
these oscillations are impaired in disease states. Necessarily,
this approach includes gaining a detailed biophysical under-
standing of how these oscillations are generated. Target
engagement focuses on identifying how stimulation para-
digms modulate brain rhythms with the goal of identifying
theoretical principles. Target validation refers to the (subse-
quent) investigation if oscillation dynamics can indeed be
restored and—most importantly—if restoring the network
Figure 1. tACS can be applied with portable, battery-powered devices as the one shown here developed by one of the authors (FF).
Stimulation current is delivered by electrically conducting silicone–carbon electrodes (inset), which are attached to the scalp with
conducting paste typically used for attaching EEG electrodes. The electrodes are relatively large (typically 5  5 cm) for broad spatial
reach of the resulting electric field. The shown montage has been used in a number of our clinical trials in which we targeted deficits in
large-scale brain functional connectivity in the alpha frequency band. tACS: transcranial alternating current stimulation; EEG: electro-
encephalogram. Photo credit: Morgan Alexander.
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neurophysiology indeed improves symptoms in patient
populations. Thus, target validation studies necessarily
include clinical outcomes together with neurophysiological
measures such as EEG.
Target identification
There is a rich literature of studying network oscillations in
systems neuroscience. Most studies have been performed in
rats and mice. For example, encoding of space and time
in the context of memory has been thoroughly investigated
in the rodent hippocampus.5 Synchronization of several
rhythmic activity patterns plays a fundamental role in that
circuit. Similarly, thanks to the relative ease of genetic
perturbations in mice, there is a number of “animal models”
of psychiatric and other central nervous system (CNS) dis-
orders. In that sense, one could conclude that there exists a
rich literature that serves the purpose of target identifica-
tion. Unfortunately, however, it has turned out that reality
is more complex than that. One striking example is the
alpha oscillation, a ubiquitous thalamocortical rhythm in
humans. The alpha oscillation is not present in small
rodents, perhaps due to the relative simplicity of the
(visual) thalamocortical system. The resulting gap between
mice and men represents a significant hurdle in the devel-
opment of targets for noninvasive brain stimulation in
humans. In addition, there is a growing consensus that there
is no “depressed mouse” or “mouse with schizophrenia”
since these complex psychiatric disorders are in many ways
truly human. This becomes very evident when one consid-
ers how simple the behavioral assessments of “disease” are
in mouse studies. Together, the focus on mouse research
over the last decade has created a significant delay in the
necessary science for target identification and ultimately
successful translation to new treatments with brain stimu-
lation (or other innovative therapeutic strategy that are
designed to target network pathology). One strategy for-
ward is the development of animal models that have a
broader shared substrate of structural and functional net-
work connectivity with humans. For example, one of the
authors (FF) has adapted the application of many of the
cutting-edge systems neuroscience techniques such as
optogenetic perturbations,6 functional magnetic resonance
imaging (fMRI),7 and touch screen–based cognitive
assays8 to the ferret (Mustela putorius furo). The ferret is
a domesticated carnivore with a gyrencephalic brain, with a
well-defined prefrontal cortex (resembling the dorsolateral
prefrontal cortex in primates9) that is missing in mice. Also,
the ferret has a quite well developed visual system that
includes columnar cortical organization, primate-like pul-
vinar complex (extrageniculate visual thalamus), and a
brain size that easily allows for multisite electrical record-
ings of brain activity with implanted electrodes. In fact, we
have recently demonstrated the clear presence of thalamo-
cortical alpha oscillations that are (like in humans) gated by
arousal.10 These oscillations occurred in the structurally
connected system of posterior parietal cortex and pulvinar
complex11 again in similarity to primates. While this is an
early step, this example demonstrates that by working with
other small mammals, model organisms can be developed
that share important features such as the alpha oscillations,
which is known to be impaired in range of psychiatric dis-
orders, including depression and schizophrenia.12,13
Target engagement
The first and most important question in the context of
modulating brain rhythms with tACS is if and how a very
weak electric field can modulate cortical rhythmic activity.
It has been known for quite a while that electric fields,
when properly aligned to the main somatodendritic axis,
can depolarize neurons.14 This depolarization is, concep-
tually spoken, the consequence of the relative electric iso-
lation of the cytosol (inside of the cell) from the
extracellular space (by the cell membrane). When an elec-
tric field is applied, it imposes an extracellular gradient of
electric potential. In contrast, in the cytosol, charge carriers
(i.e. ions) reorganize their position until the electrical field
is cancelled out. Since the membrane voltage is measured
as the difference between inside and outside of the cell, the
net consequence is an electrical polarization of the neuron.
The original interest in the effect of weak electric fields was
motivated by the question whether endogenous electric
fields that emerge from meso- and macroscale neuronal
synchronization (measured as LFP or EEG) may influence
neuronal activity. This hypothesis was mostly abandoned
since the changes in membrane potential by exposure to an
electric field are very small. The (erroneous) conclusion is
that a perturbation that does not trigger an action potential,
that is, a “subthreshold” perturbation, cannot modulate neu-
ronal activity. It is worth dissecting this fallacy. First, the
distinction into sub- and suprathreshold perturbations is an
artificial one with little benefit to understanding the effect
of electromagnetic fields applied to the nervous system.
The membrane voltage of neurons is constantly fluctuating
as a function of synaptic input and intrinsic ion channel
dynamics. Thus, a weak perturbation may have indeed little
effect on the output of a neuron (firing of an action poten-
tial). However, if the neuron is close to threshold for action
potential generation, then the same weak input can easily
trigger an action potential. As a direct consequence, the
effect of weak electric fields on the nervous system needs
to be understood in the context of the endogenous network
dynamics/oscillations, and the effect of the stimulation is a
function of the synergistic interaction with these dynamics.
In other words, the effect of stimulation is state-dependent.
In addition, it is worth noting that this mechanism of action
must include a focus on network dynamics. In fact, when the
appropriate closed-loop technology was developed and
applied to directly dissect the proposed feedback interaction
between neuronal activity and the thereby generate electric
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field, it was found that weak endogenous electric fields can
effectively guide and synchronize neuronal activity.15
With this understanding of weak electric fields estab-
lished, the next question is to identify how stimulation
parameters should be chosen to most effectively modulate
neuronal activity. Perhaps not surprisingly, the most effec-
tive enhancement of oscillations results from stimulation,
which is periodic itself (such as the sine-wave used in
tACS) and frequency matches to the endogenous network
dynamics. Large-scale computer simulations of cortical
(and more recently also thalamic networks) propose that
a principle from dynamical system theory, the so-called
Arnold tongue, applied to the modulation of network oscil-
lations by tACS.16,17 The Arnold tongue refers to the visual
depiction of the combination of stimulation parameters
(frequency and amplitude) of a periodic perturbation that
successfully entrains an oscillating system (Figure 2).
Entrainment is in essence the temporal synchronization of
the endogenous dynamics to an applied periodic force. The
Arnold tongue resembles an inverted triangle that centers
on the endogenous oscillation frequency, for which (in the-
ory) an even infinitely weak perturbation can entrain an
oscillator. An important feature of the Arnold tongue is that
there are additional “parameter zones” of entrainment at
various harmonics of the endogenous oscillation frequency.
Confirmation of the Arnold tongue in the living brain is
currently pending.
Target validation
The goal is to leverage the insights gained from target
engagement studies and to deploy these paradigms in the
form of experimental treatment paradigms in clinical trials.
It is worth noting that the unique safety profile of tACS has
allowed the rapid acceleration of the human research since
there are no concerns of unwanted offsite effects in other
organ systems. Even in contrast to transcranial magnetic
stimulation (TMS), the safety profile of tACS is more
favorable since there are no plausible reports of triggering
seizures with tACS, which is a rare but important to con-
sider side effect of at least certain TMS paradigms. In
addition, the smaller and portable nature of tACS devices
make clinical trials with tACS comparatively easy to per-
form. One of the authors (FF) has recently performed sev-
eral treatment clinical trials of tACS to establish target
engagement and target validation in schizophrenia,18
depression, and chronic pain. Several more studies are
ongoing and presentation of the findings for most of these
studies is pending. Given the potential of tACS to serve as
platform technology since many disorders of the CNS have
been found to be associated with pathological changes in
cortical oscillations, there is an urgent need to broaden and
deepen the set of clinical trials of tACS to be performed.
Importantly, these studies need to be performed as gold
standard clinical trials, which unfortunately is not that com-
mon in the field. The early transcranial direct current stimu-
lation (tDCS) and tACS literature from the last decade
comprises mostly small pilot studies that report large effect
sizes. The lack of proper double-blind study design and the
inherent publication bias toward positive results that has
affected all of biomedical research has created substantial
damage to the reputation of the field and needs to be
addressed. A clinical trial of tACS (or tDCS) requires a
robust double-blind design. From a technical viewpoint, this
requires engineering controls that ensure a double-blind
study design can be successfully deployed. Small but impor-
tant glitches can endanger the blind. For example, a stimula-
tion device with a built-in battery and a display of the charge
remaining after completion of stimulation seems to be a
helpful feature. However, any type of placebo or “sham”
stimulation will require significantly less power and thus
accidental unblinding by alert study personnel is almost
bound to happen. The other important aspect of study design
is the requirement to measure target engagement through
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Figure 2. Schematic depiction of the Arnold tongue. Parameter combinations of stimulation amplitude and frequency that cause
successful entrainment are marked in green. For small stimulation amplitudes, tuning of the stimulation frequency to the endogenous
frequency is crucial (tip of inverted triangles).
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electrophysiological or other means. This has been recog-
nized by the National Institute of Mental Health in the
United States, which now requires that the primary outcome
of clinical studies is a biological variable and not a clinical
assessment or symptom score. This shift is justified by the
number of large and expensive clinical trials that have failed
and provided no biological insights of value due to the lack
of such measurements of target engagement. This approach
is also referred to as “experimental medicine.” For tACS
studies, the obvious choice of method to determine target
engagement is EEG (or magnetoencephalography, MEG).
The temporal resolution of EEG and MEG is needed to
establish changes in rhythmic neuronal network activity
caused by stimulation. In the subsequent sections, we will
outline how the framework of target identification, engage-
ment, and validation could be applied to two disorders of the
nervous system, depression and epilepsy.
Depression
The treatment of mood disorders with brain stimulation has
a long history. Electroconvulsive therapy (ECT), where
electrical stimulation is applied to elicit electrographic sei-
zures, is an effective treatment for depression.19 However,
the procedure is quite involved since it requires general
anesthesia and some patients report cognitive side effects.
The underlying mechanism of action remains to be fully
elucidated. Conceptually, ECT aims to override endogen-
ous network dynamics. Driven by the success of ECT, sti-
mulation paradigms that deliver less energy and are thus
(perceived as) more tolerable have been under develop-
ment. The first major breakthrough in this development
was TMS,20 which now has regulatory clearance in many
countries. TMS delivers a strong magnetic field via a sti-
mulation coil. The stimulation amplitude is typically nor-
malized to the amplitude required to elicit a muscle
response by stimulation of motor cortex. The standard clin-
ical TMS paradigm consists of 10 Hz stimulation, applied
for few tens of stimulation sessions. Given the electromag-
netic properties of live tissue, TMS can be spatially tar-
geted since the magnetic field does not spread in tissue.
Thus, in combination with MRI and computer vision,
“neuronavigation” can be performed to apply the magnetic
field to a spatially defined location at the surface of the
brain. Thus, in contrast to tACS, where the stimulation
current generates a spatially diffuse electric field in the
brain, specificity of stimulation in TMS focuses on space
and not time. The stimulation location for the treatment of
depression is the dorsolateral prefrontal cortex (dl-PFC).
This target is based on a large set of imaging findings,
which support hypoactivity of left frontal areas as a net-
work marker of depression.21 Interestingly, the amount of
evidence for the successful target engagement through
imaging, that is, restoration or enhancement of left frontal
activity with fMRI, remains limited.22 The stimulation
waveform used in TMS is partially constrained by the
technology of the delivery of the magnetic field and the
tolerability of the stimulation due to activation of nerves in
the scalp. Importantly, the choice of 10 Hz has thus not
been guided by an identified target (temporal dynamics).
What is remarkable about TMS is that the 10 Hz stimula-
tion frequency falls within the alpha frequency band (8–12
Hz) and that a short sequence of 10 Hz TMS pulses
entrains alpha oscillations, at least in healthy control par-
ticipants.23 Together with the (relatively consistent) find-
ings of pathologically altered alpha oscillations in
depression, it appears fair to speculate that the potential
mechanism of action of TMS is through modulation of
alpha oscillations. Yet, there are multiple questions that
surround the mechanisms of action of TMS since more
recent, larger clinical trials that compared stimulation fre-
quencies (10 Hz versus 1 Hz) and stimulation locations
(left versus right dl-PFC) have yet to identify clinically
meaningful differences in stimulation outcomes.24 More
recently, attempts to develop stimulation paradigms for
depression that use even less energy have been pursued.
For example, synchronized TMS (sTMS) is explicitly
based on targeting alpha oscillations.25 In the sTMS
device, a set of static magnets are mounted such that they
rotate to generate an electromagnetic field in the frequency
range of alpha oscillations. The resulting electric field is
presumed to be multiple orders of magnitude lower than in
TMS. In a certain way, the underlying approach resembles
the proposed target engagement principle of tACS, the
Arnold tongue.26 The stimulation (i.e. magnet rotation)
frequency is set to the individual alpha frequency peak
of every participant, thus (in theory) situating stimulation
at the “tip” of the Arnold tongue, where even very weak
electric fields are proposed to entrain (neuronal) oscilla-
tion. Remarkably, therapeutic success seemed to depend
on if the stimulation frequency was correctly chosen. How-
ever, this finding is based on an exploratory analysis and
the main intent-to-treat outcome was negative. Neverthe-
less, one important mechanistic question of target engage-
ment is raised by this work. Alpha oscillations in the left
(frontal) hemisphere are pathologically elevated in
patients with depression,27,28 albeit it remains unclear how
robust this observation is, given the recent publication of
several negative findings and meta-analyses.29 Assuming
these elevated alpha oscillations in the left frontal areas are
indeed a marker for depression (and thus a reasonable
stimulation target), it remains unclear why a periodic per-
turbation applied in the stimulation frequency would dam-
pen and not enhance the pathological oscillations.30 One
hypothesis is that repeat enhancement of alpha oscillations
ultimately leads to a homeostatic reduction of endogenous
alpha oscillations. At this point, there are no experimental
data that speaks to this hypothesis. Another hypothesis is
that through broad spatial targeting, stimulation can
“rebalance” or “redistribute” alpha oscillations and
thereby reduce the pathologically elevated left frontal
alpha oscillations. These proposed models remain generic
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and more experimental evidence is critically needed. One
of the authors (FF) has recently performed the first clinical
trial of tACS for the treatment of depression. The study
compared 10-Hz tACS (to target alpha oscillations), 40Hz-
tACS (control frequency), and sham (placebo) stimulation
in a parallel-group design. The publication of the results is
pending. In summary, the appreciation of noninvasive
brain stimulation from the perspective of the framework
of the approach in this article (target identification, target
engagement, and target validation) leads to several conclu-
sions. First, there is a trend to move from high-amplitude
stimulation approaches that override brain activity to low-
amplitude stimulation approaches, which are hypothesized
to be more specific since they work by synergistic inter-
action with endogenous network activity patterns. This
effort requires an understanding of the mechanism of
action. Second, the therapeutic benefit (and risk/benefit
profile) of today’s noninvasive brain stimulation modal-
ities for the treatment of depression is likely far from opti-
mal since the stimulation paradigms have yet to be
optimized and targeted through rational design.
Epilepsy
Epilepsy is in many ways fundamentally different from
depression, yet it is another disease for which there are
clinically approved brain stimulation treatments. From the
perspective of target identification, epilepsy appears to be
the ideal candidate since the disease is defined by aberrant
electric network activity patterns, which could thus serve
as targets. Yet, the stimulation strategies may need to be
different since the obvious goal would be to suppress
pathological activity patterns. Thus, the conceptually
most straightforward approach is to detect the onset of a
seizure and then apply stimulation to disrupt the develop-
ment of pathological network activity. Intuitively, to
“override” large-scale pathological activity, high stimula-
tion amplitudes are required, which may need to be
delivered intracranially. Refinement of target engagement
strategies such as timing of stimulation informed by dyna-
mical models of seizures could be used to exploit
“vulnerabilities/instabilities” of seizure activity patterns.
At the level of target validation, similar problems to brain
stimulation in depression emerge. The heterogeneity of
disease manifestations and the state-dependence of patho-
logical network dynamics make the demonstration of clin-
ical efficacy challenging.
Our framework of target identification, engagement, and
validation could also be used for a paradigm-shifting
approach to brain stimulation in epilepsy, which focuses
on stabilizing and enhancing activity patterns that “protect”
the brain from developing seizures. In this approach,
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Figure 3. iEEG recorded by a depth electrode placed into the left hippocampal region of a patient with pharmacoresistant epilepsy. At
seizure onset, interictal patterns of brain activity—slower signals and spikes—disappear and are replaced by fast oscillations, which are
more clearly visualized in the spectrogram.34 Detecting, engaging, and stabilizing certain interictal patterns might reduce the probability
of seizure onset.35 iEEG: intracranial electroencephalogram.
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activity patterns which prevent individual subnetworks to
“break free” and develop pathological activity31 would rep-
resent the stimulation target. Perhaps counterintuitively and
in contradiction to the textbook model of epileptic seizures,
low-frequency, synchronized activity patterns may serve as
a mechanism to both prevent the development of seizures
and also play a crucial role in terminating seizures
(Figure 3).32,33 While more experimental evidence for this
refined model is urgently needed, this model would support
the use of low-amplitude noninvasive paradigms such as
tACS to enhance and stabilize physiological synchronization
ofnetworks toprevent the occurrenceof seizures. Thus, target
identification would focus on delineating the oscillatory
modes of “seizure protection.” Target engagement would
require an understanding if networks in the brain of patients
with epilepsy respond equally favorable to the application
of tACS and if indeed the same mechanisms such as the
Arnold tongue may apply. Finally, target validation studies
would have similar structures as for any other brain stimula-
tion study in epilepsy in terms of reducing seizure rate.
Outlook
The integrated approach for the development of novel ther-
apeutic neurotechnology proposed here combines identifi-
cation, engagement, and validation of network oscillations
as targets for tACS. This approach is motivated by the
unique synergisms of a multidisciplinary approach that
spans from computational neuroscience to clinical trials.
As simple as the underlying idea of treating pathologies
of endogenous electric fields with exogenous electric fields
is, the promise of a safe and effective treatment platform
for disorders of the brain propels the approach outlined here
is unique and deserves our full attention.
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